This drug is an angiotensin converting enzyme inhibitor.
本品是一种血管紧张素转换酶抑制剂。
Less than one-third of subjects were receiving an angiotensin converting enzyme inhibitor at baseline, although this rose to around 40% by the end of follow-up.
小于三分之一患者基线时接受了转换酶抑制剂治疗，但随访结束时，使用比例已上升至近40%。
Objective To observe the effect of benazepril, an angiotensin converting enzyme inhibitor (ACEI) , on reducing proteinuria in a nephrotic young rat model of with massive proteinuria.
目的观察血管紧张素转换酶抑制剂苯那普利减轻幼龄肾病大鼠蛋白尿的作用。
Objective To introduce the research and market development of enalapril as an angiotensin 1-converting enzyme inhibitor (ACEI) for treating hypertension.
目的介绍抗高血压药血管紧张素转化酶抑制剂（ACEI）依那普利的研发及市场情况。
Objective To introduce the research and market development of enalapril as an angiotensin 1-converting enzyme inhibitor (ACEI) for treating hypertension.
目的介绍抗高血压药血管紧张素转化酶抑制剂（ACEI）依那普利的研发及市场情况。
应用推荐